Chrystyna Stecyk
Founder chez ORION BIOTECH OPPORTUNITIES CORP.
Fortune : - $ au 31/03/2024
Profil
Chrystyna Bedrij Stecyk is the founder of PTC Therapeutics GT, Inc. (founded in 2013), Griffin Securities, Inc. (founded in 1997), and Orion Biotech Opportunities Corp.
(founded in 2021).
She holds the title of Principal at Griffin Securities, Inc. and Vice President at Orion Biotech Opportunities Corp.
Ms. Stecyk's current jobs include Director at Oncxerna Therapeutics, Inc., Director at Myrtelle LLC, Independent Director at Vaccinex, Inc., Director at Maavrx Ltd., and Manager at Aletheia Biotherapeutics LLC.
She has an MBA from The Leonard N Stern School of Business and an undergraduate degree from Vassar College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VACCINEX, INC.
-.--% | 22/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Chrystyna Stecyk
| Sociétés | Poste | Début |
|---|---|---|
| VACCINEXPAR | Director/Board Member | 14/05/2020 |
| ORION BIOTECH OPPORTUNITIES CORP. | Founder | 05/02/2021 |
Griffin Securities, Inc.
 Griffin Securities, Inc. Investment Banks/BrokersFinance Headquartered in New York City, Griffin Securities, Inc. is a research-driven investment banking firm providing corporate finance, merger & acquisitions, brokerage and investment opportunities for institutional, corporate and private clients. Orders can be entered on major U.S. exchanges and most international exchanges. Positions can be held in multiple currencies. Griffin's research focuses on delivering objective, value-added research and winning ideas in several industries including healthcare/biotechnology, technology and telecommunications. They are a member of the NASD and the SIPC. Griffin Securities was founded in 1997. | Founder | 01/01/1997 |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Director/Board Member | - |
Aletheia Biotherapeutics LLC
 Aletheia Biotherapeutics LLC Medical/Nursing ServicesHealth Services Aletheia Biotherapeutics LLC operates as a clinical stage biotechnology company. It provides cancer-associated epithelial-to-mesenchyme transition with its AB-16B5 monoclonal antibody. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Maavrx Ltd. | Director/Board Member | - |
Myrtelle LLC
 Myrtelle LLC Miscellaneous Commercial ServicesCommercial Services Myrtelle LLC is a gene therapy company that specializes in developing treatments for neurodegenerative diseases. Myrtelle is based in New York, NY. The company has a proprietary platform, intellectual property, and a portfolio of programs and technologies that support innovative gene therapy approaches. The company has an exclusive worldwide licensing agreement with Pfizer Inc. for its Canavan disease program. | Director/Board Member | - |
Anciens postes connus de Chrystyna Stecyk
| Sociétés | Poste | Fin |
|---|---|---|
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a private company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Founder | 01/07/2018 |
Formation de Chrystyna Stecyk
| Vassar College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VACCINEXPAR | Health Technology |
| Entreprise privées | 7 |
|---|---|
Griffin Securities, Inc.
Griffin Securities, Inc. Investment Banks/BrokersFinance Headquartered in New York City, Griffin Securities, Inc. is a research-driven investment banking firm providing corporate finance, merger & acquisitions, brokerage and investment opportunities for institutional, corporate and private clients. Orders can be entered on major U.S. exchanges and most international exchanges. Positions can be held in multiple currencies. Griffin's research focuses on delivering objective, value-added research and winning ideas in several industries including healthcare/biotechnology, technology and telecommunications. They are a member of the NASD and the SIPC. Griffin Securities was founded in 1997. | Finance |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a private company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Health Technology |
Aletheia Biotherapeutics LLC
Aletheia Biotherapeutics LLC Medical/Nursing ServicesHealth Services Aletheia Biotherapeutics LLC operates as a clinical stage biotechnology company. It provides cancer-associated epithelial-to-mesenchyme transition with its AB-16B5 monoclonal antibody. The company is headquartered in New York, NY. | Health Services |
Orion Biotech Opportunities Corp.
 Orion Biotech Opportunities Corp. Financial ConglomeratesFinance Orion Biotech Opportunities Corp. operates as a blank check company, which aims to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Zuie Chin Huang and Chrystyna Bedrij Stecyk on February 5, 2021 and is headquartered in New York, NY. | Finance |
| Maavrx Ltd. | |
Myrtelle LLC
Myrtelle LLC Miscellaneous Commercial ServicesCommercial Services Myrtelle LLC is a gene therapy company that specializes in developing treatments for neurodegenerative diseases. Myrtelle is based in New York, NY. The company has a proprietary platform, intellectual property, and a portfolio of programs and technologies that support innovative gene therapy approaches. The company has an exclusive worldwide licensing agreement with Pfizer Inc. for its Canavan disease program. | Commercial Services |
